Loading...
•
Mar 31, 2022
Glaukos Q1 2022 Earnings Report
Announced financial results for the first quarter of 2022.
Key Takeaways
Glaukos Corporation announced financial results for the first quarter ended March 31, 2022, with net sales of $67.7 million. The company updated its 2022 net sales guidance to $270 million to $275 million.
Net sales of $67.7 million in Q1 2022.
Glaucoma net sales of $51.5 million and Corneal Health net sales of $16.1 million in Q1 2022.
Gross margin of approximately 75% and non-GAAP gross margin of approximately 83% in Q1 2022.
Operating expenses of $40.8 million and non-GAAP operating expenses of $69.8 million in Q1 2022.
Revenue by Segment
Forward Guidance
The company expects 2022 net sales to be in the range of $270 million to $275 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...